di , 21/06/2021

Virtual Reality treatment show significant improvement for Chronic Pain Patients

We are very excited to share the great results of the Orion Corporation Clinical Trial where Healthware was the key R&D partner creating a Digital Therapeutics solution (DTx) for chronic pain patients.

A novel treatment, a Digital Therapeutics software solution for Chronic Pain (DTxP), using Virtual Reality (VR), has shown statistically significant benefit over passive (placebo) control and standard care interventions for fear of movement, patient clinical global impression of change (PGIC) and quality of life in adult patients with chronic low back pain (CLBP). Results from the pilot study were announced at the IASP 2021 Virtual World Congress On Pain.

Background: Growing opportunities with Virtual Reality

The results from this clinical trial are very positive, and it also gives hope to find a way to bring this solution to the people with chronic pain who need it. In the future we will likely see more of these kinds of solutions being developed, also for other kinds of therapies and treatments.

Read the full article by Therese Elg, Marketing & Communications Director Nordics & Baltics, Healthware International, at www.healthwaregroup.com/blog